Canada Corporation Registry

Ripple Therapeutics Corporation

Active Federal corporation 11752901 Toronto, ON Since 2019 Checked Nov 19, 2026

Ripple Therapeutics Corporation is an active federal corporation (corporation number 11752901). Its business number is 760459073. It was incorporated on Nov 22, 2019 under the Canada Business Corporations Act and its registered office is in Toronto, Ontario. Its annual returns are up to date, most recently for 2025. It has eight directors on record.

Corporate details

Corporation number
11752901
Business number
760459073
Status
Active
Governing law
Canada Business Corporations Act
Incorporated
Nov 22, 2019
Corporation type
Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2025 annual return.
Registered office
101 College Street, Suite 300
MaRS Centre, South Tower
Toronto ON M5G 1L7
Number of directors
At least 1, at most 10As the articles allow.

Annual filings

Anniversary date
Nov 22The date of incorporation, amalgamation or continuance.
Annual filing period
Nov 22 to Jan 21 each year
Last annual meeting
Dec 30, 2024
Annual returns by year
YearAnnual returnAnnual meeting
2026Not yet due Due from Nov 22, 2026
2025FiledDec 30, 2024
2024FiledDec 30, 2024

The last annual return filed, and each year since.

Directors

Loading the directors from the federal record...

Federal grants and contributions

14 agreements since 2020, worth $1,731,172 in all.

Federal grants and contributions
DepartmentProgramValueStarts
National Research Council CanadaYouth Employment - Material Engineer$30,000Jul 1, 2026
National Research Council CanadaDry AMD manufacturing development and optimization$150,000Apr 1, 2026
National Research Council CanadaDrug Product Development Engineer Support$25,000Apr 16, 2025
National Research Council CanadaR&D Engineering support$30,000Sep 12, 2024
Innovation, Science and Economic Development CanadaFR-35211$15,000Aug 30, 2024
National Research Council CanadaRTC-PG Sustained Release Prostaglandins$300,000Apr 1, 2024
National Research Council CanadaLab support$30,000Aug 1, 2023
National Research Council CanadaSustained release form targeting wet age-related macular degeneration$22,984Sep 1, 2022
National Research Council CanadaAssociate research scientist$30,000Apr 1, 2022
National Research Council CanadaIBE-814 IVT Diabetic Macular Edema and Retinal Vein Occlusion$810,564Jan 1, 2022

As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. The 10 most recent are shown. Search every federal grant.

Names

Names in use
NameFormIn use since
Ripple Therapeutics CorporationNameNov 22, 2019

Filings and certificates

Filings and certificates
WhatDate
Articles amendedNov 25, 2020
IncorporatedNov 22, 2019

Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.